After 3 years at the helm of the lifestyle health care company Alphaeon, Robert Grant is no longer chief executive officer. As first reported by Eyewiretoday.com, Mr. Grant is transitioning out of the CEO role of Alphaeon, which he founded in 2013, and will focus on private equity film Strathspey Crown, of which he is chairman.
The transaction is expected to be completed by June 30.
In an emailed statement to Eyewiretoday.com, Bill Link, managing director of Versant Ventures and Chairman of the Board at Alphaeon, confirmed the change.
“I am remaining in my role as Chairman of the Board of Alphaeon. Robert Grant, as founder, is transitioning from his CEO role at Alphaeon to focus more on Strathspey Crown activities. Robert will remain on the Alphaeon board. The Alphaeon board will initiate a search for the new CEO in the near future," the statement read.
In an Alphaeon news release issued following the Eyewiretoday.com report, Mr. Grant stated, "I am excited about this new capacity and role on the Alphaeon Board of Directors, as it allows me to focus more of my attention on exciting activities at Strathspey Crown Holdings, the majority shareholder of Alphaeon, where I serve as chairman. I remain highly dedicated to the company and our outstanding board and management team and remain committed to the vision of Alphaeon to build the first social commerce company focused in lifestyle healthcare. I would like to thank the Board of Directors and the Alphaeon employees around the world for their hard work and dedication during my tenure as CEO."
Alphaeon said Mr. Grant's transition from CEO to vice chairman of the board will be completed by June 30.
Mr. Grant, an ophthalmic industry veteran, founded Alphaeon in 2013 as a wholly owned subsidiary of Strathspey Crown LLC, a private equity firm located in Newport Beach, California, where he serves as chairman. Mr. Grant started Alphaeon to serve health care providers in the self-pay segment, primarily in plastic surgery, ophthalmology, dermatology, orthopedics, and cosmetic dentistry. Prior to Alphaeon, he was President and CEO of Bausch + Lomb Surgical from July 2010 to January 2012. He also served as president of Allergan Medical from 2006 to 2010, and prior to that, he was president and CEO of Biolase Technology.